Pharmacy Act 1868

From WikiMD's WELLNESSPEDIA

The Pharmacy Act 1868 is a significant piece of legislation in the United Kingdom that regulated the profession of pharmacy and defined the legal framework for the sale and supply of pharmaceutical drugs. This Act was the first to establish a formal qualification for pharmacists, setting a precedent for future pharmacy legislation.

Background[edit]

Prior to the Pharmacy Act 1868, there were no formal qualifications required to practice as a pharmacist in the UK. This led to a lack of standardization in the profession and potential risks to public health. The Act was introduced to address these issues and to provide a legal framework for the profession.

Provisions[edit]

The Pharmacy Act 1868 established the Pharmaceutical Society of Great Britain as the regulatory body for the profession. It also set out the qualifications required to practice as a pharmacist, including the need for a formal examination and a period of practical training.

The Act also regulated the sale and supply of pharmaceutical drugs. It made it illegal to sell certain dangerous drugs without a prescription from a qualified medical practitioner. This was a significant step in ensuring the safety of the public.

Impact[edit]

The Pharmacy Act 1868 had a significant impact on the profession of pharmacy in the UK. It led to the establishment of a standardized qualification for pharmacists and set a precedent for future pharmacy legislation. The Act also helped to ensure the safety of the public by regulating the sale and supply of pharmaceutical drugs.

See also[edit]

References[edit]


External links[edit]

Template:Justice icon

This article relating to law in the United Kingdom, or its constituent jurisdictions, is a stub. You can help WikiMD by expanding the page.

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Pharmacy_Act_1868&oldid=6630243"